CYANOTECH Business Summary

Cyanotech Corporation (CYAN) operates a vertically integrated business model focused on the cultivation, processing, and global distribution of high-value natural products derived from microalgae. The company generates revenue through two primary business segments: Packaged Products, marketed under the Nutrex Hawaii brand (including BioAstin® Hawaiian Astaxanthin® and Hawaiian Spirulina Pacifica®), and Bulk Ingredients sold to third-party manufacturers. Revenue is primarily driven by direct-to-consumer e-commerce channels, domestic retail partnerships, and international bulk ingredient contracts. Cyanotech maintains a competitive advantage through its 96-acre facility in the Kona Coast's High Sunlight Zone, which allows for year-round production using pristine deep-sea water. Its primary direct competitors include AstaReal (Fuji Chemical Industries), DIC Corporation (Earthrise Nutritionals), Valensa International, and Corbion N.V. Within this landscape, Cyanotech distinguishes itself as a premium, U.S.-sourced specialist with a focus on high-purity, clinically supported antioxidant and nutritional supplements. The company was co-founded in 1983 by Dr. Gerald R. Cysewski, who currently serves as Chief Scientific Officer and CEO Emeritus, bringing a doctorate in Chemical Engineering from UC Berkeley and a background in microalgae R&D from Battelle Northwest. The executive team is led by President and CEO Matthew K. Custer, who has over 20 years of management experience in the food and supplement industries and previously served as the company’s VP of Operations. Jennifer Miyashiro, appointed as Chief Financial Officer in August 2025, provides extensive financial leadership from her previous tenure at Hawaiian Airlines. Other key executives include Collette N. Kakuk, Chief Strategic and Commercial Officer, and Glenn D. Jensen, VP of Operations, who has been with the firm since 1984. The board is chaired by Michael A. Davis, a significant long-term investor, alongside independent directors David L. Vied and David M. Mulder, ensuring seasoned oversight of the company’s strategic pivot toward improved production efficiency and brand-driven growth.